Background The coronavirus disease 2019 (COVID-19) pandemic has led to significant
reductions in transplantation, motivated in part by concerns of disproportionately more severe …

All authors participated in conception or design of the work or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising it critically for important …

… Villanueva MD b , Lydia Aoun-Barakat MD b , Insoo Kang MD a … Maricar Malinis MD b …
Drs Topal, Dela Cruz, and Malinis contributed equally to this manuscript as senior author. …

The SARS-CoV-2 pandemic continues to place a substantial burden on healthcare systems.
Outpatient therapies for mild-to-moderate disease have reduced hospitalizations and …

Mortality among patients hospitalized for COVID‐19 has declined over the course of the
pandemic. Mortality trends specifically in solid organ transplant recipients (SOTR) are unknown. …

This updated section of the guideline from the Infectious Diseases Community of Practice of
the American Society of Transplantation reviews the screening of donor and candidate prior …

The COVID-19 pandemic has disproportionately impacted immunosuppressed patients,
including solid organ transplant recipients (SOTR). COVID-19-associated mortality among …

Liver transplantation (LT) from donors‐with‐HIV to recipients‐with‐HIV (HIV D+/R+) is permitted
under the HOPE Act. There are only three international single‐case reports of HIV D+/R…

Lung transplant recipients (LTR) with coronavirus disease 2019 (COVID‐19) may have higher
mortality than non‐lung solid organ transplant recipients (SOTR), but direct comparisons …

Background Few options are available for cytomegalovirus (CMV) treatment in transplant
recipients resistant, refractory, or intolerant to approved agents. Letermovir (LET) is approved …